Shih-Han Ko

718 total citations · 1 hit paper
12 papers, 465 citations indexed

About

Shih-Han Ko is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shih-Han Ko has authored 12 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shih-Han Ko's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (3 papers). Shih-Han Ko is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (3 papers). Shih-Han Ko collaborates with scholars based in Taiwan. Shih-Han Ko's co-authors include Han‐Chung Wu, Ruei‐Min Lu, Kang-Hao Liang, Shih-Chieh Su, Feng-Yi Ke, Woan‐Yuh Tarn, Li‐Min Huang, Yi‐Ling Lin, Ching‐Len Liao and Chia-Yi Yu and has published in prestigious journals such as The Journal of Immunology, International Journal of Molecular Sciences and Frontiers in Microbiology.

In The Last Decade

Shih-Han Ko

11 papers receiving 456 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

2022 157 citations Ruei‐Min Lu, Shih-Chieh Su et al. Journal of Biomedical Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shih-Han Ko Taiwan	9	243	216	66	43	43	12	465
Thi Khanh Le France	8	308 1.3×	230 1.1×	37 0.6×	43 1.0×	16 0.4×	11	497
Nadine Czudnochowski United States	5	347 1.4×	288 1.3×	52 0.8×	45 1.0×	43 1.0×	5	542
Emanuele Andreano Italy	11	446 1.8×	202 0.9×	89 1.3×	57 1.3×	69 1.6×	24	611
Yaara Finkel Israel	8	450 1.9×	302 1.4×	129 2.0×	71 1.7×	19 0.4×	9	698
Yuexiu Zhang United States	12	127 0.5×	228 1.1×	90 1.4×	49 1.1×	9 0.2×	13	417
Gretel M. Torres United States	4	309 1.3×	166 0.8×	100 1.5×	31 0.7×	153 3.6×	5	502
Aidong Qu China	3	323 1.3×	190 0.9×	67 1.0×	21 0.5×	67 1.6×	4	490
Ruoke Wang China	12	421 1.7×	129 0.6×	38 0.6×	93 2.2×	58 1.3×	15	520
Danhua Zhao China	6	186 0.8×	283 1.3×	94 1.4×	52 1.2×	19 0.4×	17	487
Enyue Fang China	6	185 0.8×	249 1.2×	90 1.4×	48 1.1×	18 0.4×	9	427

Countries citing papers authored by Shih-Han Ko

Since Specialization

Citations

This map shows the geographic impact of Shih-Han Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih-Han Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih-Han Ko more than expected).

Fields of papers citing papers by Shih-Han Ko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih-Han Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih-Han Ko. The network helps show where Shih-Han Ko may publish in the future.

Co-authorship network of co-authors of Shih-Han Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Shih-Han Ko. A scholar is included among the top collaborators of Shih-Han Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih-Han Ko. Shih-Han Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Kumari, Monika, Shih-Chieh Su, Hsiu-Ting Lin, et al.. (2025). Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residue. Vaccine. 57. 127216–127216. 1 indexed citations

2.

Lu, Ruei‐Min, Hsiao-Ling Chiang, Kang-Hao Liang, et al.. (2025). Technological advancements in antibody-based therapeutics for treatment of diseases. Journal of Biomedical Science. 32(1). 98–98.

3.

Lu, Ruei‐Min, Monika Kumari, Guanhong Chen, et al.. (2024). Current landscape of mRNA technologies and delivery systems for new modality therapeutics. Journal of Biomedical Science. 31(1). 89–89. 34 indexed citations

4.

Kumari, Monika, Ruei‐Min Lu, Mu‐Chun Li, et al.. (2022). A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. Journal of Biomedical Science. 29(1). 68–68. 94 indexed citations

5.

Lu, Ruei‐Min, Shih-Chieh Su, Shih-Han Ko, et al.. (2022). Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. Journal of Biomedical Science. 29(1). 1–1. 157 indexed citations breakdown →

6.

Ko, Shih-Han, Chen Wy, Shih-Chieh Su, et al.. (2022). Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants. Journal of Biomedical Science. 29(1). 108–108. 7 indexed citations

7.

Lu, Ruei‐Min, Shih-Han Ko, Chen Wy, et al.. (2021). Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19. International Journal of Molecular Sciences. 22(22). 12412–12412. 18 indexed citations

8.

Tarn, Woan‐Yuh, et al.. (2021). Antisense Oligonucleotide-Based Therapy of Viral Infections. Pharmaceutics. 13(12). 2015–2015. 44 indexed citations

9.

Liang, Kang-Hao, Shih-Han Ko, Yu‐Chi Chou, et al.. (2021). Antibody cocktail effective against variants of SARS-CoV-2. Journal of Biomedical Science. 28(1). 80–80. 17 indexed citations

10.

Ko, Shih-Han, Li‐Min Huang, & Woan‐Yuh Tarn. (2019). The Host Heat Shock Protein MRJ/DNAJB6 Modulates Virus Infection. Frontiers in Microbiology. 10. 2885–2885. 18 indexed citations

11.

Ko, Shih-Han, Ya‐Hui Chi, Yu-Ping Chiang, et al.. (2018). Interference of DNAJB6/MRJ Isoform Switch by Morpholino Inhibits Replication of HIV-1 and RSV. Molecular Therapy — Nucleic Acids. 14. 251–261. 13 indexed citations

12.

Yu, Chia-Yi, et al.. (2013). Ubiquitin-Specific Protease 13 Regulates IFN Signaling by Stabilizing STAT1. The Journal of Immunology. 191(6). 3328–3336. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact